145 related articles for article (PubMed ID: 36763762)
1. Two women with primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder during pregnancy.
Gambichler T; Scheel CH; Kock K; Klapper W; Doerler M; Boms S
Clin Exp Dermatol; 2023 Apr; 48(5):533-535. PubMed ID: 36763762
[No Abstract] [Full Text] [Related]
2. Coincident Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder in Two Sisters.
Ponce S; Peñate Y; Montenegro T
Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):271-273. PubMed ID: 31980130
[No Abstract] [Full Text] [Related]
3. Ultrasound findings in case series of patients with primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Recio-Monescillo M; Mendoza-Cembranos MD; Torre-Castro J; Moya-Martínez C; Ruffin-Vicente B; Díaz-Recuero JL; Córdoba R; López-Robles J; Pelayo I; Rodríguez-Pinilla M; Requena L
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):e320-e322. PubMed ID: 37907275
[No Abstract] [Full Text] [Related]
4. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors.
Sarac E; Demirkesen C
An Bras Dermatol; 2023; 98(5):720-722. PubMed ID: 37225627
[No Abstract] [Full Text] [Related]
5. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
Leeolou MC; Young PA; Saleem A; Narala S; Bae GH
Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809093
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous CD4
Besch-Stokes JG; Costello CM; Severson KJ; Bhullar P; Montoya J; Butterfield RJ; DiCaudo DJ; Comfere N; Sluzevich J; Rule W; Craig FE; Rosenthal A; Pittelkow MR; Mangold AR
J Am Acad Dermatol; 2022 May; 86(5):1167-1169. PubMed ID: 33915243
[No Abstract] [Full Text] [Related]
7. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
Salah E
J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
[TBL] [Abstract][Full Text] [Related]
9. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Valentim FO; Oliveira CC; Miot HA
An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
[TBL] [Abstract][Full Text] [Related]
10. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous CD4
Takei I; Kawai K; Nakajima M; Ansai O; Anan T
J Dermatol; 2021 May; 48(5):e212-e214. PubMed ID: 33624292
[No Abstract] [Full Text] [Related]
12. Primary cutaneous CD4
Jiang Y; Liu D; Alnasri A
Indian J Dermatol Venereol Leprol; 2020; 86(6):726-729. PubMed ID: 33063707
[No Abstract] [Full Text] [Related]
13. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.
Plumptre IR; Said JT; Sun T; Larocca C; Virgen CA; Kupper TS; Fisher DC; Devlin PM; Elco CP; Song JS; LeBoeuf NR
Leuk Lymphoma; 2022 Dec; 63(12):2832-2846. PubMed ID: 35862569
[TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorders.
Soderquist CR; Hsiao S; Pang J; Gru AA; Husain S; Alobeid B; Bhagat G
Hematol Oncol; 2023 Oct; 41(4):768-770. PubMed ID: 37010271
[No Abstract] [Full Text] [Related]
15. Primary cutaneous CD4
Plumptre IR; Said JT; Sheu Song J; Corey K; LeBoeuf NR
Pediatr Blood Cancer; 2022 Sep; 69(9):e29862. PubMed ID: 35730956
[TBL] [Abstract][Full Text] [Related]
16. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analysis of primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoproliferative disorder: a retrospective study of 22 patients.
Shi HZ; Zhang J; Xiong JS; Gan L; Jiang YQ; Xu XL; Zhang W; Zeng XS; Sun JF; Chen H
Int J Dermatol; 2021 Apr; 60(4):497-502. PubMed ID: 33369742
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series.
Surmanowicz P; Doherty S; Sivanand A; Parvinnejad N; Deschenes J; Schneider M; Hardin J; Gniadecki R
Dermatology; 2021; 237(4):618-628. PubMed ID: 33326960
[TBL] [Abstract][Full Text] [Related]
19. Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus-A Report of Two Cases.
Yi LG; Gru AA
Am J Dermatopathol; 2021 Dec; 43(12):e293-e297. PubMed ID: 34001748
[TBL] [Abstract][Full Text] [Related]
20. Dermoscopy of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Rodríguez-Lomba E; Lobato-Berezo A; Pulido-Pérez A; Parra-Blanco V; Avilés-Izquierdo JA
Int J Dermatol; 2020 Jun; 59(6):755-757. PubMed ID: 32010958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
